Our website uses cookies to improve your on-site experience. By using the website, cookies are being used as described in our Policy Document
Warning: To log in you will need to enable cookies and reload the page (Policy Document)
My ePortfolio Register   

Combined chemo-radiation extends survival in patients with anaplastic oligodendroglial tumours

Please rate this video

Please complete at least one question.

  1. The information in this video was of interest to me Disagree Agree
  2. The information in this video is likely to improve my clinical practice or research Disagree Agree
  3. I would recommend this video to my colleagues Disagree Agree
Thanks for rating
There has been a problem, please refresh and try again.
Published: 03.06.12
Views: 3806

Dr Martin Van Den Bent - Erasmus University Medical Center, Rotterdam, Netherlands

At a press conference during the ASCO 2012 Annual Meeting in Chicago, June 1st - June 4th, Dr Martin Van Den Bent presented findings from a phase III study showing that combination chemotherapy after standard radiation therapy delayed tumour growth and extended the lives of patients with anaplastic oligodendroglial tumours, a form of brain cancer.


A sub-analysis of the study showed the survival benefit of combination chemotherapy-radiation treatment may be limited to patients whose tumours contained specific deletions of genetic material in chromosomes 1 and 19. 

Related videos

follow us

Immuno-oncology advances in cancer treatment e-learning

Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

ecancer Global Foundation